Showing 20 of 112 recruiting trials for “Adult hepatocellular carcinoma”
Application of mRNA Vaccine in Liver Transplantation for Hepatocellular Carcinoma
To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients
RecruitingNCT07345247 ↗
RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study
Study of GV20-0251 in Participants With Solid Tumor Malignancies
A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)
PIN in Combination With Anti-PD1 in Previously Treated Primary Hepatocellular Carcinoma
👨⚕️ Weidong Han, Ph.D, Biotherapeutic Department, Chinese PLA General Hospital📍 1 site📅 Started Jun 2025View details ↗
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
RecruitingNCT06877637 ↗
On-treatment Surveillance of Tumor Evolution and Response to Systemic Treatment in Bile Duct and Liver Cancer
Hyperpolarized 13C-MRI in Patients With Hepatocellular Carcinoma Undergoing Radiotherapy, Atezolizumab, and Bevacizumab
RecruitingNCT06999174 ↗
Multiparametric MRI for Characterization of Hepatocellular Carcinoma
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Lenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTT
👨⚕️ Kangshun Zhu, Dr., Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started Apr 2025View details ↗
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Microbiota Modification for Immuno-oncology in Hepatocellular Carcinoma
👨⚕️ Héloise BOURIEN, Dr, Centre de lutte contre le cancer Eugène Marquis📍 6 sites📅 Started Mar 2025View details ↗
Hepatic Arterial Infusion Chemotherapy and Immunotherapy for Hepatocellular Carcinoma
A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative Treatment
RecruitingNCT06746194 ↗
The Value of 68Ga-FAPI PET/CT in the Efficacy Evaluation of Advanced Unresectable Hepatocellular Carcinoma Patients Undergoing Systemic Antitumor Therapy
RecruitingNCT06813508 ↗
Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH
👨⚕️ Fabio Piscaglia, Prof, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 1 site📅 Started Nov 2024View details ↗
Mts105 for Advanced Hepatocellular Carcinoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →